Elevated circulating ketone bodies during SGLT-2 therapy in diabetic patients has been correlated with reduced activity of the pattern receptor recognition protein: the NLRP3 inflammasome complex in macrophages, which is a pathway of innate immunity important in the pathogenesis of atherosclerosis and coronary heart disease [23]. The gene discussed is NLRP3; the disease is atherosclerosis.